Smith Joins Orchid Cellmark as VP and CFO; Dermtech Taps Quackenbush for SAB; Transgenomic Hires Richards as Senior VP; and Others | GenomeWeb
NEW YORK (GenomeWeb News) - Orchid Cellmark has named James Smith to the post of VP and CFO. Smith formerly was executive VP and CFO of Aphton, and before that he was VP and global controller of Ansell/ Smith.He also served as a senior executive in finance and accounting at Wyeth and American Cyanamid Company.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.